FGFR2 and colorectal cancer: We then tested FGFR2 staining in a set of four colorectal cancer tissue microarrays, representing two hundred forty-nine primary samples, fifty eight lymph node metastases, and fifteen liver metastases, and found FGFR2 staining in four primary tumors and one lymph node metastasis (1.5% of all samples).